Skip to main content

Table 3 GST genotype distribution according to predicted enzyme activity

From: No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case–control study

GST

GST genotypes

Predicted enzyme activity

ESCC (n = 106)#

EAC (n = 327)#

Controls (n = 592)#

GST M1

*1/*1 & *1/*0

High-Intermediate

48 (45.7%)

156 (47.7%)

273 (46.2%)

*0/*0

Low

57 (54.3%)

171 (52.3%)

318 (53.8%)

GST A1

*1a/*1a

High

43 (41.3%)

131 (42.1%)

214 (37.2%)

*1a/*1b

Intermediate

50 (48.1%)

133 (42.8%)

277 (48.2%)

*1b/*1b

Low

11 (10.6%)

47 (15.1%)

84 (14.6%)

GST P1 I105V

Ile / Ile

High

48 (45.7%)

119 (37.5%)

246 (41.6%)

Ile / Val

Intermediate

42 (40.0%)

157 (49.5%)

261 (44.2%)

Val / Val

Low

15 (14.3%)

41 (12.9%)

84 (14.2%)

GST P1 A114V

Ala / Ala

High

92 (86.8%)

262 (82.6%)

485 (83.5%)

Ala / Val

Intermediate

14 (13.2%)

52 (16.4%)

91 (15.7%)

Val / Val

Low

0

3 (0.9%)

5 (0.9%)

GST T1

*1/*1 & *1/*0

High-Intermediate

87 (82.9%)

248 (75.8%)

463 (78.3%)

*0/*0

Low

18 (17.1%)

79 (24.2%)

128 (21.7%)

  1. ESSC esophageal squamous cell carcinoma, EAC esophageal adenocarcinoma.
  2. #Some genotyping data were missing due to PCR bias.